Stephen Hubbs

Stephen Hubbs is an experienced scientist specializing in small molecule process development, currently serving as Scientist I at Alexion Pharmaceuticals, Inc. since January 2021, following a role as Associate Scientist IV in the same division. Prior to Alexion, Stephen held the position of Senior Research Scientist at Genesis Biotechnology Group from March 2020 to January 2021 and worked at FORMA Therapeutics for a decade, starting as a scientist in August 2009 and concluding in April 2019. Stephen's career began at Pfizer where employment spanned from August 1998 to April 2009 as a scientist. Stephen earned a Bachelor of Science degree in Chemistry from Rensselaer Polytechnic Institute between 1996 and 1998.